Neuphoria Therapeutics(DE:B1N0)
€1.610.00 (0.00%)
DE:B1N0
Neuphoria Therapeutics earnings date
€1.61
At close:0.00 (0.00%)
Neuphoria Therapeutics (B1N0) Q4 2022 Earnings Report
2 Followers
DE:B1N0 Q4 2022 EPS Results
- Actual EPS
- -EUR 12.15
- Consensus EPS
- -EUR 1,023.96
- Beat/Miss
- Beat by +EUR 1,011.81
- One Year Ago EPS
- -EUR 0.01
DE:B1N0 Q4 2022 Revenue Results
- Actual Revenue
- EUR 166.35K
- Expected Revenue
- EUR 254.59K
- Beat/Miss
- Missed by -EUR 88.24K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 08/25/2022
- Time
- Before Open
- Conference Call
- Thursday, August 25, 2022
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B1N0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 29, 2025 | 2025 (Q4) | -1.82-2.31 | -25.64 | 91.00% (+23.33) | |
| Feb 20, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Aug 21, 2024 | 2024 (Q4) | -0.83-0.83 | -0.93 | 10.23% (+0.09) | |
| Feb 22, 2024 | 2024 (Q2) | ―-0.93 | -1.29 | 28.10% (+0.36) | |
| Aug 23, 2023 | 2023 (Q4) | -0.98- | -1.01 | ― | |
| Feb 23, 2023 | 2023 (Q2) | -7.00-15.49 | -5.37 | -188.32% (-10.12) | |
| Aug 25, 2022 | 2022 (Q4) | ―-12.15 | -0.01 | -153677.78% (-12.14) | |
| Feb 22, 2022 | 2022 (Q2) | -10.79-5.37 | 0 | ― | |
| Aug 25, 2021 | 2021 (Q4) | 0.00-0.01 | 0 | ― | |
| Feb 26, 2021 | 2021 (Q2) | 0.000.00 | -0.98 | 100.00% (+0.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

